Literature DB >> 28144834

Society for Health Psychology (APA Division 38) and Society of Behavioral Medicine joint position statement on the Medicare Diabetes Prevention Program.

Stephanie L Fitzpatrick1, Dawn K Wilson2, Sherry L Pagoto3.   

Abstract

Beginning in January 2018, the Centers for Medicare and Medicaid Services (CMS) plans to cover the Diabetes Prevention Program (DPP), also referred to as Medicare DPP. The American Psychological Association Society for Health Psychology (SfHP) and the Society for Behavioral Medicine (SBM) reviewed the proposed plan. SfHP and SBM are in support of the CMS decision to cover DPP for Medicare beneficiaries but have a significant concern that aspects of the proposal will limit the public health impact. Concerns include the emphasis on weight outcomes to determine continued coverage and the lack of details regarding requirements for coaches. SfHP and SBM are in strong support of modifications to the proposal that would remove the minimum weight loss stipulation to determine coverage and to specify type and qualifications of "coaches."

Entities:  

Keywords:  Diabetes; Medicare; Policy; Weight loss

Mesh:

Year:  2017        PMID: 28144834      PMCID: PMC5526812          DOI: 10.1007/s13142-017-0468-2

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.046


  6 in total

1.  Will Obesity Treatment Reimbursement Benefit Those at Highest Risk?

Authors:  Gary G Bennett; Dori M Steinberg; Sherry L Pagoto
Journal:  Am J Med       Date:  2015-02-16       Impact factor: 4.965

Review 2.  Clinical review: modified 5 As: minimal intervention for obesity counseling in primary care.

Authors:  Michael Vallis; Helena Piccinini-Vallis; Arya M Sharma; Yoni Freedhoff
Journal:  Can Fam Physician       Date:  2013-01       Impact factor: 3.275

3.  Do the five A's work when physicians counsel about weight loss?

Authors:  Stewart C Alexander; Mary E Cox; Christy L Boling Turer; Pauline Lyna; Truls Østbye; James A Tulsky; Rowena J Dolor; Kathryn I Pollak
Journal:  Fam Med       Date:  2011-03       Impact factor: 1.756

4.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

5.  10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

Authors:  William C Knowler; Sarah E Fowler; Richard F Hamman; Costas A Christophi; Heather J Hoffman; Anne T Brenneman; Janet O Brown-Friday; Ronald Goldberg; Elizabeth Venditti; David M Nathan
Journal:  Lancet       Date:  2009-10-29       Impact factor: 79.321

6.  An Evidence-based Guide for Obesity Treatment in Primary Care.

Authors:  Stephanie L Fitzpatrick; Danielle Wischenka; Bradley M Appelhans; Lori Pbert; Monica Wang; Dawn K Wilson; Sherry L Pagoto
Journal:  Am J Med       Date:  2015-07-31       Impact factor: 4.965

  6 in total
  2 in total

1.  A 6-year update of the health policy and advocacy priorities of the Society of Behavioral Medicine.

Authors:  Joanna Buscemi; Gary G Bennett; Sherri Sheinfeld Gorin; Sherry L Pagoto; James F Sallis; Dawn K Wilson; Marian L Fitzgibbon
Journal:  Transl Behav Med       Date:  2017-12       Impact factor: 3.046

2.  Challenges with implementing the Diabetes Prevention Program for Medicare beneficiaries in an integrated health system.

Authors:  Inga Gruß; Alison Firemark; Dea Papajorgji-Taylor; Stephanie L Fitzpatrick
Journal:  Am J Manag Care       Date:  2021-11-01       Impact factor: 3.247

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.